ERBB2 and neoplasm: Besides the effects of the oncomiRs levels determined immediately after the surgical removal of the tumor, risk characteristics like triple-negativity, HER2, grade II, and axillary lymphadenopathy as well as type of therapy or family history have no effect on the probability of relapse.